Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 4c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/3/2026

1. AAPL
2. PLTR
3. VRTX
4. CHKP
5. ON
6. CRWD
7. HNGE
8. INSP
9. MRVL
10. MTCH

Go back to Xenon Pharmaceuticals (XENE) Tops Q2 EPS by 4c

Xenon Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update

August 7, 2018 4:01 PM EDT

Novel Epilepsy Product Candidates XEN1101 and XEN901 Continue to Advance in the Clinic

New XEN1101 Phase 1b TMS Pharmacodynamic Data to be Presented at upcoming European Congress on Epileptology

BURNABY, British Columbia, Aug. 07, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a clinical stage biopharmaceutical company, today reported its financial results for the quarter ended June 30, 2018 and provided a corporate update.

Dr. Simon Pimstone, Xenons Chief Executive Officer, said, As I reflect... More